Epigenesis in acute myeloid leukemia: an update

Area of Science:

• Hematology
• Oncology
• Molecular Biology
• Epigenetics

Background:

• Acute myeloid leukemia (AML) is a cancer of blood-forming tissues.
• It is characterized by the rapid proliferation of abnormal myeloid precursor cells.
• This uncontrolled growth disrupts normal blood cell production, leading to bone marrow failure.

Purpose of the Study:

• To review the role of genetic and epigenetic alterations in AML pathogenesis.
• To highlight how epigenetic dysregulation contributes to leukemogenesis.
• To emphasize the multifactorial nature of AML development.

Main Methods:

• Literature review of current research on AML genetics and epigenetics.
• Analysis of studies detailing chromosomal abnormalities and molecular mutations in AML.
• Examination of evidence linking epigenetic modifications to altered gene regulation in hematopoiesis.

Main Results:

• Approximately 55% of AML cases exhibit chromosomal rearrangements.
• About 45% of AML cases present with normal karyotypes but have detectable molecular mutations.
• Abnormal DNA methylation, histone modifications, and non-coding RNA expression are implicated in AML development.

Conclusions:

• AML pathogenesis involves both genetic mutations and epigenetic dysregulation.
• Epigenetic mechanisms play a crucial role in the abnormal regulation of hematopoietic genes.
• These epigenetic alterations can drive the transition from normal hematopoiesis to leukemogenesis.